-
1
-
-
0141788413
-
Prefrontal da transmission at D1 receptors and the pathology of schizophrenia
-
Abi-Dargham A., Moore H. (2003) Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9: 404-416.
-
(2003)
Neuroscientist
, vol.9
, pp. 404-416
-
-
Abi-Dargham, A.1
Moore, H.2
-
2
-
-
0034608753
-
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia
-
Abi-Dargham A., Rodenhiser J., Printz D., et al. (2000) Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A 97: 8104-8109.
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, pp. 8104-8109
-
-
Abi-Dargham, A.1
Rodenhiser, J.2
Printz, D.3
-
3
-
-
47249116664
-
Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective disorder
-
Adams DH, Close S., Farmen M., Downing AM, Breier A. and Houston JP (2008) Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective disorder. Hum Psychopharmacol 23 (4). 267-274.
-
(2008)
Hum Psychopharmacol
, vol.23
, Issue.4
, pp. 267-274
-
-
Adams, D.H.1
Close, S.2
Farmen, M.3
Downing, A.M.4
Breier, A.5
Houston, J.P.6
-
4
-
-
0025140780
-
Depression dexamethasone nonsuppression and negative symptoms in schizophrenia
-
Addington D., Addington J. (1990) Depression dexamethasone nonsuppression and negative symptoms in schizophrenia. Can J Psychiatry 35: 430-433.
-
(1990)
Can J Psychiatry
, vol.35
, pp. 430-433
-
-
Addington, D.1
Addington, J.2
-
5
-
-
34249085382
-
Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response-a double-blind PET study in schizophrenia
-
Agid O., Mamo D., Ginovart N., Vitcu I., Wilson AA, Zipursky RB, Kapur S. (2007) Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response-a double-blind PET study in schizophrenia. Neuropsychopharmacology 32: 1209-1215.
-
(2007)
Neuropsychopharmacology
, vol.32
, pp. 1209-1215
-
-
Agid, O.1
Mamo, D.2
Ginovart, N.3
Vitcu, I.4
Wilson, A.A.5
Zipursky, R.B.6
Kapur, S.7
-
6
-
-
47649127177
-
Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting
-
Alenius M., Wadelius M., Dahl ML, Hartvig P., Lindstrom L. and Hammarlund-Udenaes M. (2008) Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting. J Psychiatr Res 42 (11). 884-893.
-
(2008)
J Psychiatr Res
, vol.42
, Issue.11
, pp. 884-893
-
-
Alenius, M.1
Wadelius, M.2
Dahl, M.L.3
Hartvig, P.4
Lindstrom, L.5
Hammarlund-Udenaes, M.6
-
7
-
-
0025325739
-
Relationships between clinical effects and monoamine metabolites and amino acids in sulpiridetreated schizophrenic patients
-
Berl
-
Alfredsson G., Wiesel FA (1990) Relationships between clinical effects and monoamine metabolites and amino acids in sulpiridetreated schizophrenic patients. Psychopharmacology (Berl) 101: 324-331.
-
(1990)
Psychopharmacology
, vol.101
, pp. 324-331
-
-
Alfredsson, G.1
Wiesel, F.A.2
-
9
-
-
0028917102
-
Assessment of the central dopaminergic index of plasma HVA in schizophrenia
-
Amin F., Davidson M., Kahn RS, et al. (1995) Assessment of the central dopaminergic index of plasma HVA in schizophrenia. Schizophr Bull 21: 53-66.
-
(1995)
Schizophr Bull
, vol.21
, pp. 53-66
-
-
Amin, F.1
Davidson, M.2
Kahn, R.S.3
-
10
-
-
0042882523
-
The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes
-
Arango C., Breier A., McMahon R., Carpenter WT, Jr, Buchanan RW (2003) The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes. Am J Psychiatry 160: 1421-1427.
-
(2003)
Am J Psychiatry
, vol.160
, pp. 1421-1427
-
-
Arango, C.1
Breier, A.2
McMahon, R.3
Buchanan, R.W.4
-
11
-
-
0029100429
-
Association between clozapine response and allelic variation in 5-HT2A receptor gene
-
Arranz M., Collier D., Sodhi M., et al. (1995) Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet 346 (8970). 281-282.
-
(1995)
Lancet
, vol.346
, Issue.8970
, pp. 281-282
-
-
Arranz, M.1
Collier, D.2
Sodhi, M.3
-
12
-
-
0034092912
-
The serotonin transporter and clozapine response
-
Arranz MJ, Bolonna AA, Munro J., Curtis CJ, Collier DA, Kerwin RW (2000 a) The serotonin transporter and clozapine response. Mol Psychiatry 5: 124-125.
-
(2000)
Mol Psychiatry
, vol.5
, pp. 124-125
-
-
Arranz, M.J.1
Bolonna, A.A.2
Munro, J.3
Curtis, C.J.4
Collier, D.A.5
Kerwin, R.W.6
-
13
-
-
0030592571
-
Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine
-
Arranz MJ, Collier DA, Munro J., et al. (1996) Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine. Neurosci Lett 217: 177-178.
-
(1996)
Neurosci Lett
, vol.217
, pp. 177-178
-
-
Arranz, M.J.1
Collier, D.A.2
Munro, J.3
-
14
-
-
34547469943
-
Pharmacogenetics and pharmacogenomics of schizophrenia: A review of last decade of research
-
Arranz MJ, de Leon J. (2007) Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research. Mol Psychiatry 12: 707-747.
-
(2007)
Mol Psychiatry
, vol.12
, pp. 707-747
-
-
Arranz, M.J.1
De Leon, J.2
-
15
-
-
0032217288
-
Lack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and clozapine response
-
Arranz MJ, Li T., Munro J., et al. (1998) Lack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and clozapine response. Pharmacogenetics 8 (6). 481-484. (Pubitemid 29043380)
-
(1998)
Pharmacogenetics
, vol.8
, Issue.6
, pp. 481-484
-
-
Arranz, M.J.1
Li, T.2
Munro, J.3
Liu, X.4
Murray, R.5
Collier, D.A.6
Kerwin, R.W.7
-
16
-
-
0034648927
-
Difficulties in replication of results
-
Arranz MJ, Munro J., Osborne S., Collier D., Kerwin RW (2000 b) Difficulties in replication of results. Lancet 356 (9238). 1359-1360.
-
(2000)
Lancet
, vol.356
, Issue.9238
, pp. 1359-1360
-
-
Arranz, M.J.1
Munro, J.2
Osborne, S.3
Collier, D.4
Kerwin, R.W.5
-
17
-
-
0021235828
-
Neuroendocrine differences among subtypes of schizophrenic disorder? An investigation with the dexamethasone suppression test
-
Banki CM, Arato M., Rihmer Z. (1984) Neuroendocrine differences among subtypes of schizophrenic disorder? An investigation with the dexamethasone suppression test. Neuropsychobiology 11: 174-177.
-
(1984)
Neuropsychobiology
, vol.11
, pp. 174-177
-
-
Banki, C.M.1
Arato, M.2
Rihmer, Z.3
-
18
-
-
58849142941
-
(2009) Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients
-
Barlas IO, Cetin M., Erdal ME, et al. (2009) Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients. Am J Med Genet B Neuropsychiatr Genet 150B (1). 56-60.
-
Am J Med Genet B Neuropsychiatr Genet
, vol.150
, Issue.1
, pp. 56-60
-
-
Barlas, I.O.1
Cetin, M.2
Erdal, M.E.3
-
19
-
-
0242490991
-
Medicare and medicaid costs for schizophrenia patients by age cohort compared with costs for depression, dementia, and medically ill patients
-
Bartels SJ, Clark RE, Peacock WJ, Dums AR, Pratt SI (2003) Medicare and medicaid costs for schizophrenia patients by age cohort compared with costs for depression, dementia, and medically ill patients. Am J Geriatr Psychiatry 11: 648-657.
-
(2003)
Am J Geriatr Psychiatry
, vol.11
, pp. 648-657
-
-
Bartels, S.J.1
Clark, R.E.2
Peacock, W.J.3
Dums, A.R.4
Pratt, S.I.5
-
20
-
-
4744376592
-
Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia
-
Bertolino A., Caforio G., Blasi G., et al. (2004) Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am J Psychiatry 161 (10). 1798-1805.
-
(2004)
Am J Psychiatry
, vol.161
, Issue.10
, pp. 1798-1805
-
-
Bertolino, A.1
Caforio, G.2
Blasi, G.3
-
21
-
-
34548160606
-
COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia
-
Bertolino A., Caforio G., Blasi G., et al. (2007) COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia. Schizophr Res 95: 253-255.
-
(2007)
Schizophr Res
, vol.95
, pp. 253-255
-
-
Bertolino, A.1
Caforio, G.2
Blasi, G.3
-
22
-
-
0012820694
-
Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response
-
Birkett JT, Arranz MJ, Munro J., Osbourn S., Kerwin RW, Collier DA (2000) Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response. Neuroreport 11: 2017-2020.
-
(2000)
Neuroreport
, vol.11
, pp. 2017-2020
-
-
Birkett, J.T.1
Arranz, M.J.2
Munro, J.3
Osbourn, S.4
Kerwin, R.W.5
Collier, D.A.6
-
23
-
-
23444450578
-
Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment
-
Bishop JR, Ellingrod VL, Moline J., Miller D. (2005) Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment. Schizophr Res 77: 253-260.
-
(2005)
Schizophr Res
, vol.77
, pp. 253-260
-
-
Bishop, J.R.1
Ellingrod, V.L.2
Moline, J.3
Miller, D.4
-
24
-
-
0033956560
-
No influence of adrenergic receptor polymorphisms on schizophrenia and antipsychotic response
-
Bolonna AA, Arranz MJ, Munro J., et al. (2000) No influence of adrenergic receptor polymorphisms on schizophrenia and antipsychotic response. Neurosci Lett 280: 65-68.
-
(2000)
Neurosci Lett
, vol.280
, pp. 65-68
-
-
Bolonna, A.A.1
Arranz, M.J.2
Munro, J.3
-
25
-
-
0021241811
-
Plasma catecholamine metabolites and early response to haloperidol
-
Bowers MB, Jr, Swigar ME, Jatlow PI, Goicoechea N. (1984) Plasma catecholamine metabolites and early response to haloperidol. J Clin Psychiatry 45: 248-251.
-
(1984)
J Clin Psychiatry
, vol.45
, pp. 248-251
-
-
Swigar, M.E.1
Jatlow, P.I.2
Goicoechea, N.3
-
26
-
-
0024512548
-
Plasma catecholamine metabolites and treatment response at neuroleptic steady state
-
Bowers MB, Jr, Swigar ME, Jatlow PI, Hoffman FJ (1989) Plasma catecholamine metabolites and treatment response at neuroleptic steady state. Biol Psychiatry 25: 734-738.
-
(1989)
Biol Psychiatry
, vol.25
, pp. 734-738
-
-
Swigar, M.E.1
Jatlow, P.I.2
Hoffman, F.J.3
-
27
-
-
0030776916
-
Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: A within-subject comparison with haloperidol
-
Brown AS, Gewirtz G., Harkavy-Friedman J., et al. (1997) Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol. Neuropsychopharmacology 17: 317-325.
-
(1997)
Neuropsychopharmacology
, vol.17
, pp. 317-325
-
-
Brown, A.S.1
Gewirtz, G.2
Harkavy-Friedman, J.3
-
28
-
-
0028785179
-
New insights into the biology of schizophrenia through the mechanism of action of clozapine
-
Brunello N., Masotto C., Steardo L., Markstein R., Racagni G. (1995) New insights into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology 13: 177-213.
-
(1995)
Neuropsychopharmacology
, vol.13
, pp. 177-213
-
-
Brunello, N.1
Masotto, C.2
Steardo, L.3
Markstein, R.4
Racagni, G.5
-
29
-
-
0031746826
-
Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome
-
Buchanan RW, Breier A., Kirkpatrick B., Ball P., Carpenter WT, Jr (1998) Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome. Am J Psychiatry 155: 751-760.
-
(1998)
Am J Psychiatry
, vol.155
, pp. 751-760
-
-
Buchanan, R.W.1
Breier, A.2
Kirkpatrick, B.3
Ball, P.4
-
30
-
-
0026467217
-
Striatal metabolic rate and clinical response to neuroleptics in schizophrenia
-
Buchsbaum MS, Potkin SG, Siegel BV, Jr, et al. (1992) Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch Gen Psychiatry 49 (12). 966-974.
-
(1992)
Arch Gen Psychiatry
, vol.49
, Issue.12
, pp. 966-974
-
-
Buchsbaum, M.S.1
Potkin, S.G.2
-
31
-
-
0019435794
-
A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility
-
Carroll BJ, Feinberg M., Greden JF, et al. (1981) A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry 38: 15-22.
-
(1981)
Arch Gen Psychiatry
, vol.38
, pp. 15-22
-
-
Carroll, B.J.1
Feinberg, M.2
Greden, J.F.3
-
32
-
-
33751001329
-
Dopamine D2 receptor occupancy by risperidone: Implications for the timing and magnitude of clinical response
-
Catafau AM, Corripio I., Perez V., Martin JC, Schotte A., Carrio I., Alvarez E. (2006) Dopamine D2 receptor occupancy by risperidone: implications for the timing and magnitude of clinical response. Psychiatry Res 148: 175-183.
-
(2006)
Psychiatry Res
, vol.148
, pp. 175-183
-
-
Catafau, A.M.1
Corripio, I.2
Perez, V.3
Martin, J.C.4
Schotte, A.5
Carrio, I.6
Alvarez, E.7
-
33
-
-
0035076468
-
The changes of biological markers and treatment efficacy in schizophrenia
-
Ceskova E., Drybcak P., Hrobar P., Lorenc M., Prochazkova H., Spacek J. (2001) The changes of biological markers and treatment efficacy in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 25: 323-335.
-
(2001)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.25
, pp. 323-335
-
-
Ceskova, E.1
Drybcak, P.2
Hrobar, P.3
Lorenc, M.4
Prochazkova, H.5
Spacek, J.6
-
34
-
-
0036016287
-
Biological markers and possibilities for predicting therapeutic results in schizophrenia: A methodological contribution
-
Ceskova E., Drybcak P., Lorenc M. (2002) Biological markers and possibilities for predicting therapeutic results in schizophrenia: a methodological contribution. Prog Neuropsychopharmacol Biol Psychiatry 26: 683-691.
-
(2002)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.26
, pp. 683-691
-
-
Ceskova, E.1
Drybcak, P.2
Lorenc, M.3
-
35
-
-
0025275157
-
Plasma catecholamine metabolites in schizophrenics: Evidence for the two-subtype concept
-
Chang WH, Chen TY, Lin SK, et al. (1990) Plasma catecholamine metabolites in schizophrenics: evidence for the two-subtype concept. Biol Psychiatry 27: 510-518.
-
(1990)
Biol Psychiatry
, vol.27
, pp. 510-518
-
-
Chang, W.H.1
Chen, T.Y.2
Lin, S.K.3
-
36
-
-
0038009306
-
Association analysis of the genetic variants of the N-methyl D-aspartate receptor subunit 2b (NR2b) and treatment-refractory schizophrenia in the Chinese
-
Chiu HJ, Wang YC, Liou YJ, Lai IC, Chen JY (2003) Association analysis of the genetic variants of the N-methyl D-aspartate receptor subunit 2b (NR2b) and treatment-refractory schizophrenia in the Chinese. Neuropsychobiology 47 (4). 178-181.
-
(2003)
Neuropsychobiology
, vol.47
, Issue.4
, pp. 178-181
-
-
Chiu, H.J.1
Wang, Y.C.2
Liou, Y.J.3
Lai, I.C.4
Chen, J.Y.5
-
37
-
-
0032587535
-
Polymorphisms of the dopamine D4 receptor and response to antipsychotic drugs
-
Berl
-
Cohen BM, Ennulat DJ, Centorrino F., et al. (1999) Polymorphisms of the dopamine D4 receptor and response to antipsychotic drugs. Psychopharmacology (Berl) 141 (1). 6-10.
-
(1999)
Psychopharmacology
, vol.141
, Issue.1
, pp. 6-10
-
-
Cohen, B.M.1
Ennulat, D.J.2
Centorrino, F.3
-
38
-
-
0020531027
-
Dexamethasone suppression test in depression and other psychiatric illness
-
Coppen A., Abou-Saleh M., Milln P., Metcalfe M., Harwood J., Bailey J. (1983) Dexamethasone suppression test in depression and other psychiatric illness. Br J Psychiatry 142: 498-504.
-
(1983)
Br J Psychiatry
, vol.142
, pp. 498-504
-
-
Coppen, A.1
Abou-Saleh, M.2
Milln, P.3
Metcalfe, M.4
Harwood, J.5
Bailey, J.6
-
39
-
-
33748864195
-
Investigation of possible association between Ser9Gly polymorphism of the D3 dopaminergic receptor gene and response to typical antipsychotics in patients with schizophrenia
-
Cordeiro Q., Miguita K., Miracca E., Elkis H. and Vallada H. (2006) Investigation of possible association between Ser9Gly polymorphism of the D3 dopaminergic receptor gene and response to typical antipsychotics in patients with schizophrenia. Sao Paulo Med J 124 (3). 165-167.
-
(2006)
Sao Paulo Med J
, vol.124
, Issue.3
, pp. 165-167
-
-
Cordeiro, Q.1
Miguita, K.2
Miracca, E.3
Elkis, H.4
Vallada, H.5
-
40
-
-
10944267670
-
Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: A 123I-IBZM study with ziprasidone and haloperidol
-
Corripio I., Catafau AM, Perez V., et al. (2005) Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol. Prog Neuropsychopharmacol Biol Psychiatry 29: 91-96.
-
(2005)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.29
, pp. 91-96
-
-
Corripio, I.1
Catafau, A.M.2
Perez, V.3
-
41
-
-
0017255979
-
Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs
-
Creese I., Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192: 481-483.
-
(1976)
Science
, vol.192
, pp. 481-483
-
-
Creese, I.1
Burt, D.R.2
Snyder, S.H.3
-
42
-
-
0018899460
-
Molecular pathology of schizophrenia: More than one disease process
-
Crow TJ (1980) Molecular pathology of schizophrenia: more than one disease process ? Br Med J 280 (6207). 66-68.
-
(1980)
Br Med J
, vol.280
, Issue.6207
, pp. 66-68
-
-
Crow, T.J.1
-
43
-
-
0029037226
-
Effect of clozapine on d-fenfluramine-evoked neuroendocrine responses in schizophrenia and its relationship to clinical improvement
-
Curtis VA, Wright P., Reveley A., Kerwin R., Lucey JV (1995) Effect of clozapine on d-fenfluramine-evoked neuroendocrine responses in schizophrenia and its relationship to clinical improvement. Br J Psychiatry 166: 642-646.
-
(1995)
Br J Psychiatry
, vol.166
, pp. 642-646
-
-
Curtis, V.A.1
Wright, P.2
Reveley, A.3
Kerwin, R.4
Lucey, J.V.5
-
44
-
-
0027461574
-
Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia
-
Davidson M., Kahn RS, Stern RG, et al. (1993) Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia. Psychiatry Res 46 (2). 151-163.
-
(1993)
Psychiatry Res
, vol.46
, Issue.2
, pp. 151-163
-
-
Davidson, M.1
Kahn, R.S.2
Stern, R.G.3
-
45
-
-
0023923529
-
Plasma homovanillic acid as a predictor of response to neuroleptics
-
Davila R., Manero E., Zumarraga M., Andia I., Schweitzer JW, Friedhoff AJ (1988) Plasma homovanillic acid as a predictor of response to neuroleptics. Arch Gen Psychiatry 45 (6). 564-567.
-
(1988)
Arch Gen Psychiatry
, vol.45
, Issue.6
, pp. 564-567
-
-
Davila, R.1
Manero, E.2
Zumarraga, M.3
Andia, I.4
Schweitzer, J.W.5
Friedhoff, A.J.6
-
46
-
-
0035113905
-
A revised excitotoxic hypothesis of schizophrenia: Therapeutic implications
-
Deutsch SI, Rosse RB, Schwartz BL, Mastropaolo J. (2001) A revised excitotoxic hypothesis of schizophrenia: therapeutic implications. Clin Neuropharmacol 24 (1). 43-49.
-
(2001)
Clin Neuropharmacol
, vol.24
, Issue.1
, pp. 43-49
-
-
Deutsch, S.I.1
Rosse, R.B.2
Schwartz, B.L.3
Mastropaolo, J.4
-
47
-
-
0019946065
-
Abnormal dexamethasone suppression test results in chronic schizophrenic patients
-
Dewan MJ, Pandurangi AK, Boucher ML, Levy BF, Major LF (1982) Abnormal dexamethasone suppression test results in chronic schizophrenic patients. Am J Psychiatry 139 (11). 1501-1503.
-
(1982)
Am J Psychiatry
, vol.139
, Issue.11
, pp. 1501-1503
-
-
Dewan, M.J.1
Pandurangi, A.K.2
Boucher, M.L.3
Levy, B.F.4
Major, L.F.5
-
48
-
-
0027441907
-
Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics
-
Duncan E., Wolkin A., Angrist B., et al. (1993) Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics. Biol Psychiatry 34 (8). 523-528.
-
(1993)
Biol Psychiatry
, vol.34
, Issue.8
, pp. 523-528
-
-
Duncan, E.1
Wolkin, A.2
Angrist, B.3
-
49
-
-
0026503249
-
PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients
-
Farde L., Nordstrom AL (1992) PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients. Br J Psychiatry Suppl 17). 30-33.
-
(1992)
Br J Psychiatry Suppl
, vol.17
, pp. 30-33
-
-
Farde, L.1
Nordstrom, A.L.2
-
50
-
-
36849051883
-
No association between the DRD3 Ser9Gly polymorphism and schizophrenia
-
Fathalli F., Rouleau GA, Xiong L., et al. (2008) No association between the DRD3 Ser9Gly polymorphism and schizophrenia. Schizophr Res 98 (1-3). 98-104.
-
(2008)
Schizophr Res
, vol.98
, Issue.1-3
, pp. 98-104
-
-
Fathalli, F.1
Rouleau, G.A.2
Xiong, L.3
-
51
-
-
0026970230
-
The relationship of structural brain imaging parameters to antipsychotic treatment response: A review
-
Friedman L., Lys C., Schulz SC (1992) The relationship of structural brain imaging parameters to antipsychotic treatment response: a review. J Psychiatry Neurosci 17 (2). 42-54.
-
(1992)
J Psychiatry Neurosci
, vol.17
, Issue.2
, pp. 42-54
-
-
Friedman, L.1
Lys, C.2
Schulz, S.C.3
-
52
-
-
0027131737
-
Negative symptoms of schizophrenia and the dexamethasone suppression test
-
Garyfallos G., Lavrentiadis G., Amoutzias D., Monas K., Manos N. (1993) Negative symptoms of schizophrenia and the dexamethasone suppression test. Acta Psychiatr Scand 88 (6). 425-428.
-
(1993)
Acta Psychiatr Scand
, vol.88
, Issue.6
, pp. 425-428
-
-
Garyfallos, G.1
Lavrentiadis, G.2
Amoutzias, D.3
Monas, K.4
Manos, N.5
-
53
-
-
0037087350
-
Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine
-
Goff DC, Hennen J., Lyoo IK, et al. (2002) Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine. Biol Psychiatry 51 (6). 493-497.
-
(2002)
Biol Psychiatry
, vol.51
, Issue.6
, pp. 493-497
-
-
Goff, D.C.1
Hennen, J.2
Lyoo, I.K.3
-
54
-
-
0027327459
-
Haloperidol response and plasma catecholamines and their metabolites
-
Green AI, Alam MY, Boshes RA, et al. (1993 a) Haloperidol response and plasma catecholamines and their metabolites. Schizophr Res 10 (1). 33-37.
-
(1993)
Schizophr Res
, vol.10
, Issue.1
, pp. 33-37
-
-
Green, A.I.1
Alam, M.Y.2
Boshes, R.A.3
-
55
-
-
0027411804
-
Clozapine response and plasma catecholamines and their metabolites
-
Green AI, Alam MY, Sobieraj JT, et al. (1993 b) Clozapine response and plasma catecholamines and their metabolites. Psychiatry Res 46 (2). 139-149.
-
(1993)
Psychiatry Res
, vol.46
, Issue.2
, pp. 139-149
-
-
Green, A.I.1
Alam, M.Y.2
Sobieraj, J.T.3
-
56
-
-
0038388945
-
Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo
-
Grunder G., Vernaleken I., Muller MJ, et al. (2003) Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo. Neuropsychopharmacology 28 (4). 787-794.
-
(2003)
Neuropsychopharmacology
, vol.28
, Issue.4
, pp. 787-794
-
-
Grunder, G.1
Vernaleken, I.2
Muller, M.J.3
-
57
-
-
0036843194
-
Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response
-
Gutierrez B., Arranz MJ, Huezo-Diaz P., et al. (2002) Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response. Schizophr Res 58 (1). 93-97.
-
(2002)
Schizophr Res
, vol.58
, Issue.1
, pp. 93-97
-
-
Gutierrez, B.1
Arranz, M.J.2
Huezo-Diaz, P.3
-
58
-
-
33846907203
-
Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: Associations with dopamine and serotonin receptor and transporter polymorphisms
-
Guzey C., Scordo MG, Spina E., Landsem VM and Spigset O. (2007) Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms. Eur J Clin Pharmacol 63 (3). 233-241.
-
(2007)
Eur J Clin Pharmacol
, vol.63
, Issue.3
, pp. 233-241
-
-
Guzey, C.1
Scordo, M.G.2
Spina, E.3
Landsem, V.M.4
Spigset, O.5
-
59
-
-
0035703938
-
Association analysis for NMDA receptor subunit 2B (GRIN2B) genetic variants and psychopathology and clozapine response in schizophrenia
-
Hong CJ, Yu YW, Lin CH, Cheng CY, Tsai SJ (2001) Association analysis for NMDA receptor subunit 2B (GRIN2B) genetic variants and psychopathology and clozapine response in schizophrenia. Psychiatr Genet 11 (4). 219-222.
-
(2001)
Psychiatr Genet
, vol.11
, Issue.4
, pp. 219-222
-
-
Hong, C.J.1
Yu, Y.W.2
Lin, C.H.3
Cheng, C.Y.4
Tsai, S.J.5
-
60
-
-
26644464161
-
Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations
-
Berl
-
Hwang R., Shinkai T., De Luca V., et al. (2005) Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations. Psychopharmacology (Berl) 181 (1). 179-187.
-
(2005)
Psychopharmacology
, vol.181
, Issue.1
, pp. 179-187
-
-
Hwang, R.1
Shinkai, T.2
De Luca, V.3
-
61
-
-
34548854787
-
Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response
-
Hwang R., Shinkai T., De Luca V., et al. (2007) Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response. J Psychopharmacol 21 (7). 718-727.
-
(2007)
J Psychopharmacol
, vol.21
, Issue.7
, pp. 718-727
-
-
Hwang, R.1
Shinkai, T.2
De Luca, V.3
-
62
-
-
17544400122
-
Dopamine D4 receptor gene polymorphisms and neuroleptic response in schizophrenia
-
Hwu HG, Hong CJ, Lee YL, Lee PC and Lee SF (1998) Dopamine D4 receptor gene polymorphisms and neuroleptic response in schizophrenia. Biol Psychiatry 44 (6). 483-487.
-
(1998)
Biol Psychiatry
, vol.44
, Issue.6
, pp. 483-487
-
-
Hwu, H.G.1
Hong, C.J.2
Lee, Y.L.3
Lee, P.C.4
Lee, S.F.5
-
63
-
-
0242586089
-
Interaction between angiotensin-converting enzyme and catechol-O-methyltransferase genotypes in schizophrenics with poor response to conventional neuroleptics
-
Illi A., Kampman O., Anttila S., et al. (2003) Interaction between angiotensin-converting enzyme and catechol-O-methyltransferase genotypes in schizophrenics with poor response to conventional neuroleptics. Eur Neuropsychopharmacol 13 (3). 147-151.
-
(2003)
Eur Neuropsychopharmacol
, vol.13
, Issue.3
, pp. 147-151
-
-
Illi, A.1
Kampman, O.2
Anttila, S.3
-
64
-
-
34250635128
-
Catechol-O-methyltransferase val108/158met genotype and response to antipsychotic medication in schizophrenia
-
Illi A., Kampman O., Hanninen K., et al. (2007) Catechol-O- methyltransferase val108/158met genotype and response to antipsychotic medication in schizophrenia. Hum Psychopharmacol 22 (4). 211-215.
-
(2007)
Hum Psychopharmacol
, vol.22
, Issue.4
, pp. 211-215
-
-
Illi, A.1
Kampman, O.2
Hanninen, K.3
-
65
-
-
0042322722
-
Relationship between catechol-O-methyltransferase polymorphism and treatment-resistant schizophrenia
-
Inada T., Nakamura A. and Iijima Y. (2003) Relationship between catechol-O-methyltransferase polymorphism and treatment-resistant schizophrenia. Am J Med Genet B Neuropsychiatr Genet 120B (1). 35-39.
-
(2003)
Am J Med Genet B Neuropsychiatr Genet
, vol.120
, Issue.1
, pp. 35-39
-
-
Inada, T.1
Nakamura, A.2
Iijima, Y.3
-
66
-
-
0025038719
-
Plasma HVA in psychiatric patients: Longitudinal studies
-
Javaid JI, Sharma RP, Janicak PG, Davis JM (1990) Plasma HVA in psychiatric patients: longitudinal studies. Psychopharmacol Bull 26 (3). 361-365.
-
(1990)
Psychopharmacol Bull
, vol.26
, Issue.3
, pp. 361-365
-
-
Javaid, J.I.1
Sharma, R.P.2
Janicak, P.G.3
Davis, J.M.4
-
67
-
-
0001278077
-
Management of negative symptoms of schizophrenia
-
Javitt DC (2001) Management of negative symptoms of schizophrenia. Curr Psychiatry Rep 3 (5). 413-417.
-
(2001)
Curr Psychiatry Rep
, vol.3
, Issue.5
, pp. 413-417
-
-
Javitt, D.C.1
-
68
-
-
33646832723
-
Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patients
-
Javitt DC (2006) Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patients. Curr Opin Psychiatry 19 (2). 151-157.
-
(2006)
Curr Opin Psychiatry
, vol.19
, Issue.2
, pp. 151-157
-
-
Javitt, D.C.1
-
69
-
-
0031745928
-
Neuroendocrine evidence that clozapines serotonergic antagonism is relevant to its efficacy in treating hallucinations and other positive schizophrenic symptoms
-
Jones H., Curtis VA, Wright P., Lucey JV (1998) Neuroendocrine evidence that clozapines serotonergic antagonism is relevant to its efficacy in treating hallucinations and other positive schizophrenic symptoms. Am J Psychiatry 155 (6). 838-840.
-
(1998)
Am J Psychiatry
, vol.155
, Issue.6
, pp. 838-840
-
-
Jones, H.1
Curtis, V.A.2
Wright, P.3
Lucey, J.V.4
-
70
-
-
0037114888
-
D-fenfluramine-evoked serotonergic responses in olanzapine-treated schizophrenic patients
-
Jones H., Curtis VA, Wright P., Pilowsky LS, Lucey JV (2002) D-fenfluramine-evoked serotonergic responses in olanzapine-treated schizophrenic patients. Psychiatry Res 113 (1-2). 41-47.
-
(2002)
Psychiatry Res
, vol.113
, Issue.1-2
, pp. 41-47
-
-
Jones, H.1
Curtis, V.A.2
Wright, P.3
Pilowsky, L.S.4
Lucey, J.V.5
-
71
-
-
0027268149
-
Serotonin function and treatment response to clozapine in schizophrenic patients
-
Kahn RS, Davidson M., Siever L., Gabriel S., Apter S., Davis KL (1993) Serotonin function and treatment response to clozapine in schizophrenic patients. Am J Psychiatry 150 (9). 1337-1342.
-
(1993)
Am J Psychiatry
, vol.150
, Issue.9
, pp. 1337-1342
-
-
Kahn, R.S.1
Davidson, M.2
Siever, L.3
Gabriel, S.4
Apter, S.5
Davis, K.L.6
-
72
-
-
0033945594
-
Dopamine D4 receptor 48-bp repeat polymorphism: No association with response to antipsychotic treatment, but association with catatonic schizophrenia
-
Kaiser R., Konneker M., Henneken M., et al. (2000) Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia. Mol Psychiatry 5 (4). 418-424.
-
(2000)
Mol Psychiatry
, vol.5
, Issue.4
, pp. 418-424
-
-
Kaiser, R.1
Konneker, M.2
Henneken, M.3
-
73
-
-
0036366101
-
Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia
-
Kaiser R., Tremblay PB, Klufmoller F., Roots I. and Brockmoller J. (2002) Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia. Mol Psychiatry 7 (7). 695-705.
-
(2002)
Mol Psychiatry
, vol.7
, Issue.7
, pp. 695-705
-
-
Kaiser, R.1
Tremblay, P.B.2
Klufmoller, F.3
Roots, I.4
Brockmoller, J.5
-
74
-
-
0023812652
-
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine
-
Kane J., Honigfeld G., Singer J., Meltzer H. (1988) Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45 (9). 789-796.
-
(1988)
Arch Gen Psychiatry
, vol.45
, Issue.9
, pp. 789-796
-
-
Kane, J.1
Honigfeld, G.2
Singer, J.3
Meltzer, H.4
-
75
-
-
33644876274
-
Correlation between plasma homovanillic acid levels and the response to atypical antipsychotics in male patients with schizophrenia
-
Kaneda Y., Kawamura I., Ohmori T. (2005) Correlation between plasma homovanillic acid levels and the response to atypical antipsychotics in male patients with schizophrenia. Clin Neuropharmacol 28 (6). 262-264.
-
(2005)
Clin Neuropharmacol
, vol.28
, Issue.6
, pp. 262-264
-
-
Kaneda, Y.1
Kawamura, I.2
Ohmori, T.3
-
76
-
-
0035660215
-
Dopamine D(2) receptors and their role in atypical antipsychotic action: Still necessary and may even be sufficient
-
Kapur S., Remington G. (2001) Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biol Psychiatry 50 (11). 873-883.
-
(2001)
Biol Psychiatry
, vol.50
, Issue.11
, pp. 873-883
-
-
Kapur, S.1
Remington, G.2
-
77
-
-
0020327692
-
Influence of dopamine agonists on plasma and brain levels of homovanillic acid
-
Kendler KS, Heninger GR, Roth RH (1982) Influence of dopamine agonists on plasma and brain levels of homovanillic acid. Life Sci 30 (24). 2063-2069.
-
(1982)
Life Sci
, vol.30
, Issue.24
, pp. 2063-2069
-
-
Kendler, K.S.1
Heninger, G.R.2
Roth, R.H.3
-
78
-
-
38649086421
-
Could HTR2A T102C and DRD3 Ser9Gly predict clinical improvement in patients with acutely exacerbated schizophrenia? Results from treatment responses to risperidone in a naturalistic setting
-
Kim B., Choi EY, Kim CY, Song K., Joo YH (2008) Could HTR2A T102C and DRD3 Ser9Gly predict clinical improvement in patients with acutely exacerbated schizophrenia? Results from treatment responses to risperidone in a naturalistic setting. Hum Psychopharmacol 23 (1). 61-67.
-
(2008)
Hum Psychopharmacol
, vol.23
, Issue.1
, pp. 61-67
-
-
Kim, B.1
Choi, E.Y.2
Kim, C.Y.3
Song, K.4
Joo, Y.H.5
-
79
-
-
0030940989
-
Dopamine D4 receptor gene polymorphisms: Relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects
-
Kohn Y., Ebstein RP, Heresco-Levy U., et al. (1997) Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects. Eur Neuropsychopharmacol 7 (1). 39-43.
-
(1997)
Eur Neuropsychopharmacol
, vol.7
, Issue.1
, pp. 39-43
-
-
Kohn, Y.1
Ebstein, R.P.2
Heresco-Levy, U.3
-
80
-
-
0028121087
-
Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment response
-
Koreen AR, Lieberman J., Alvir J., et al. (1994) Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment response. Arch Gen Psychiatry 51 (2). 132-138.
-
(1994)
Arch Gen Psychiatry
, vol.51
, Issue.2
, pp. 132-138
-
-
Koreen, A.R.1
Lieberman, J.2
Alvir, J.3
-
81
-
-
0036713871
-
Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene
-
Lane HY, Chang YC, Chiu CC, Chen ML, Hsieh MH, Chang WH (2002) Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene. Am J Psychiatry 159 (9). 1593-1595.
-
(2002)
Am J Psychiatry
, vol.159
, Issue.9
, pp. 1593-1595
-
-
Lane, H.Y.1
Chang, Y.C.2
Chiu, C.C.3
Chen, M.L.4
Hsieh, M.H.5
Chang, W.H.6
-
82
-
-
12344260363
-
Dopamine D3 receptor Ser9Gly polymorphism and risperidone response
-
Lane HY, Hsu SK, Liu YC, Chang YC, Huang CH and Chang WH (2005) Dopamine D3 receptor Ser9Gly polymorphism and risperidone response. J Clin Psychopharmacol 25 (1). 6-11.
-
(2005)
J Clin Psychopharmacol
, vol.25
, Issue.1
, pp. 6-11
-
-
Lane, H.Y.1
Hsu, S.K.2
Liu, Y.C.3
Chang, Y.C.4
Huang, C.H.5
Chang, W.H.6
-
83
-
-
0029555412
-
Magnetic resonance imaging and single photon emission tomography in treatment-responsive and treatment-resistant schizophrenia
-
Lawrie SM, Ingle GT, Santosh CG, et al. (1995) Magnetic resonance imaging and single photon emission tomography in treatment-responsive and treatment-resistant schizophrenia. Br J Psychiatry 167 (2). 202-210.
-
(1995)
Br J Psychiatry
, vol.167
, Issue.2
, pp. 202-210
-
-
Lawrie, S.M.1
Ingle, G.T.2
Santosh, C.G.3
-
84
-
-
40449123512
-
CATIE and CUtLASS: Can we handle the truth
-
Lewis S., Lieberman J. (2008) CATIE and CUtLASS: can we handle the truth ? Br J Psychiatry 192 (3). 161-163.
-
(2008)
Br J Psychiatry
, vol.192
, Issue.3
, pp. 161-163
-
-
Lewis, S.1
Lieberman, J.2
-
85
-
-
0032821589
-
Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective
-
Lieberman JA (1999) Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry 46 (6). 729-739.
-
(1999)
Biol Psychiatry
, vol.46
, Issue.6
, pp. 729-739
-
-
Lieberman, J.A.1
-
87
-
-
0002964661
-
No evidence for association of serotonin-2A receptor variant (102T/C) with schizophrenia or clozapine response in a Chinese population
-
Lin CH, Tsai SJ, Yu YW, et al. (1999) No evidence for association of serotonin-2A receptor variant (102T/C) with schizophrenia or clozapine response in a Chinese population. Neuroreport 10 (1). 57-60.
-
(1999)
Neuroreport
, vol.10
, Issue.1
, pp. 57-60
-
-
Lin, C.H.1
Tsai, S.J.2
Yu, Y.W.3
-
88
-
-
0029949349
-
Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine
-
Litman RE, Su TP, Potter WZ, Hong WW, Pickar D. (1996) Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine. Br J Psychiatry 168 (5). 571-579.
-
(1996)
Br J Psychiatry
, vol.168
, Issue.5
, pp. 571-579
-
-
Litman, R.E.1
Su, T.P.2
Potter, W.Z.3
Hong, W.W.4
Pickar, D.5
-
89
-
-
0029790119
-
Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine
-
Malhotra AK, Goldman D., Ozaki N., Breier A., Buchanan R., Pickar D. (1996 a) Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine. Am J Psychiatry 153 (8). 1092-1094.
-
(1996)
Am J Psychiatry
, vol.153
, Issue.8
, pp. 1092-1094
-
-
Malhotra, A.K.1
Goldman, D.2
Ozaki, N.3
Breier, A.4
Buchanan, R.5
Pickar, D.6
-
90
-
-
0029658220
-
Clozapine response and the 5HT2C Cys23Ser polymorphism
-
Malhotra AK, Goldman D., Ozaki N., et al. (1996 b) Clozapine response and the 5HT2C Cys23Ser polymorphism. Neuroreport 7 (13). 2100-2102.
-
(1996)
Neuroreport
, vol.7
, Issue.13
, pp. 2100-2102
-
-
Malhotra, A.K.1
Goldman, D.2
Ozaki, N.3
-
91
-
-
0031594223
-
The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: A haplotype relative risk study and association with clozapine response
-
Malhotra AK, Goldman D., Buchanan RW, et al. (1998) The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response. Mol Psychiatry 3 (1). 72-75.
-
(1998)
Mol Psychiatry
, vol.3
, Issue.1
, pp. 72-75
-
-
Malhotra, A.K.1
Goldman, D.2
Buchanan, R.W.3
-
92
-
-
0031861847
-
Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients
-
Masellis M., Basile V., Meltzer HY, et al. (1998) Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients. Neuropsychopharmacology 19 (2). 123-132.
-
(1998)
Neuropsychopharmacology
, vol.19
, Issue.2
, pp. 123-132
-
-
Masellis, M.1
Basile, V.2
Meltzer, H.Y.3
-
93
-
-
0035863032
-
Lack of association between the T->C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia
-
Masellis M., Basile VS, Meltzer HY, et al. (2001) Lack of association between the T->C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia. Schizophr Res 47 (1). 49-58.
-
(2001)
Schizophr Res
, vol.47
, Issue.1
, pp. 49-58
-
-
Masellis, M.1
Basile, V.S.2
Meltzer, H.Y.3
-
94
-
-
0028862241
-
Genetic variation of 5-HT2A receptor and response to clozapine
-
Masellis M., Paterson AD, Badri F., et al. (1995) Genetic variation of 5-HT2A receptor and response to clozapine. Lancet 346 (8982). 1108.
-
(1995)
Lancet
, vol.346
, Issue.8982
, pp. 1108
-
-
Masellis, M.1
Paterson, A.D.2
Badri, F.3
-
95
-
-
0028123460
-
Prediction of response to haloperidol in schizophrenia: Neuroendocrine, neuromorphological and clinical variables
-
Mauri MC, Vita A., Giobbio GM, et al. (1994) Prediction of response to haloperidol in schizophrenia: neuroendocrine, neuromorphological and clinical variables. Int Clin Psychopharmacol 9 (1). 3-7.
-
(1994)
Int Clin Psychopharmacol
, vol.9
, Issue.1
, pp. 3-7
-
-
Mauri, M.C.1
Vita, A.2
Giobbio, G.M.3
-
96
-
-
0026046111
-
Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis
-
Mazure CM, Nelson JC, Jatlow PI, Bowers MB (1991) Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis. Biol Psychiatry 30 (5). 475-482.
-
(1991)
Biol Psychiatry
, vol.30
, Issue.5
, pp. 475-482
-
-
Mazure, C.M.1
Nelson, J.C.2
Jatlow, P.I.3
Bowers, M.B.4
-
97
-
-
0021327419
-
Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms
-
Meltzer HY, Kolakowska T., Fang VS, et al. (1984) Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms. Arch Gen Psychiatry 41 (5). 512-519.
-
(1984)
Arch Gen Psychiatry
, vol.41
, Issue.5
, pp. 512-519
-
-
Meltzer, H.Y.1
Kolakowska, T.2
Fang, V.S.3
-
98
-
-
0032570653
-
Prolactin response to D-fenfluramine challenge test as a predictor of treatment response to haloperidol in acute schizophrenia
-
Mohr P., Horacek J., Motlova L., Libiger J., Czobor P. (1998) Prolactin response to D-fenfluramine challenge test as a predictor of treatment response to haloperidol in acute schizophrenia. Schizophr Res 30 (1). 91-99.
-
(1998)
Schizophr Res
, vol.30
, Issue.1
, pp. 91-99
-
-
Mohr, P.1
Horacek, J.2
Motlova, L.3
Libiger, J.4
Czobor, P.5
-
99
-
-
34548185207
-
Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: Influence on the severity of psychotic symptoms and on the response to neuroleptic treatment
-
Molero P., Ortuno F., Zalacain M. and Patino-Garcia A. (2007) Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment. Pharmacogenomics J 7 (6). 418-426.
-
(2007)
Pharmacogenomics J
, vol.7
, Issue.6
, pp. 418-426
-
-
Molero, P.1
Ortuno, F.2
Zalacain, M.3
Patino-Garcia, A.4
-
100
-
-
0345596216
-
SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine
-
Molina Rodriguez V., Montz Andree R., Perez Castejon MJ, Capdevila Garcia E., Carreras Delgado JL, Rubia Vila FJ (1996) SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine. Am J Psychiatry 153 (10). 1343-1346.
-
(1996)
Am J Psychiatry
, vol.153
, Issue.10
, pp. 1343-1346
-
-
Molina Rodriguez, V.1
Montz Andree, R.2
Perez Castejon, M.J.3
Capdevila Garcia, E.4
Carreras Delgado, J.L.5
Rubia Vila, F.J.6
-
101
-
-
10744222659
-
Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia
-
Molina V., Reig S., Pascau J., et al. (2003 a) Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia. Psychiatry Res 124 (3). 163-175.
-
(2003)
Psychiatry Res
, vol.124
, Issue.3
, pp. 163-175
-
-
Molina, V.1
Reig, S.2
Pascau, J.3
-
102
-
-
10744227822
-
Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia
-
DOI 10.1016/S0925-4927(03)00108-2
-
Molina V., Reig S., Sarramea F., et al. (2003 b) Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia. Psychiatry Res 124 (3). 153-161. (Pubitemid 37410343)
-
(2003)
Psychiatry Research - Neuroimaging
, vol.124
, Issue.3
, pp. 153-161
-
-
Molina, V.1
Reig, S.2
Sarramea, F.3
Sanz, J.4
Artaloytia, J.F.5
Luque, R.6
Aragues, M.7
Pascau, J.8
Benito, C.9
Palomo, T.10
Desco, M.11
-
103
-
-
3142621070
-
Direct association between orbitofrontal atrophy and the response of psychotic symptoms to olanzapine in schizophrenia
-
Molina V., Sanz J., Benito C., Palomo T. (2004) Direct association between orbitofrontal atrophy and the response of psychotic symptoms to olanzapine in schizophrenia. Int Clin Psychopharmacol 19 (4). 221-228.
-
(2004)
Int Clin Psychopharmacol
, vol.19
, Issue.4
, pp. 221-228
-
-
Molina, V.1
Sanz, J.2
Benito, C.3
Palomo, T.4
-
104
-
-
42949126347
-
Clozapine may partially compensate for task-related brain perfusion abnormalities in risperidone-resistant schizophrenia patients
-
Molina V., Tamayo P., Montes C., et al. (2008) Clozapine may partially compensate for task-related brain perfusion abnormalities in risperidone-resistant schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry 32 (4). 948-954.
-
(2008)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.32
, Issue.4
, pp. 948-954
-
-
Molina, V.1
Tamayo, P.2
Montes, C.3
-
105
-
-
0021359017
-
The dexamethasone suppression test in residual schizophrenia with depression
-
Munro JG, Hardiker TM, Leonard DP (1984) The dexamethasone suppression test in residual schizophrenia with depression. Am J Psychiatry 141 (2). 250-252.
-
(1984)
Am J Psychiatry
, vol.141
, Issue.2
, pp. 250-252
-
-
Munro, J.G.1
Hardiker, T.M.2
Leonard, D.P.3
-
106
-
-
0030935816
-
First-episode neuroleptic-free schizophrenics: Concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment
-
Nagaoka S., Iwamoto N., Arai H. (1997) First-episode neuroleptic-free schizophrenics: concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment. Biol Psychiatry 41 (8). 857-864.
-
(1997)
Biol Psychiatry
, vol.41
, Issue.8
, pp. 857-864
-
-
Nagaoka, S.1
Iwamoto, N.2
Arai, H.3
-
107
-
-
2642572803
-
Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1
-
Neville MJ, Johnstone EC, Walton RT (2004) Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 23 (6). 540-545.
-
(2004)
Hum Mutat
, vol.23
, Issue.6
, pp. 540-545
-
-
Neville, M.J.1
Johnstone, E.C.2
Walton, R.T.3
-
108
-
-
33744499186
-
Catechol-O-methyltransferase and monoamine oxidase-A polymorphisms and treatment response to typical and atypical neuroleptics
-
Nolan KA, Czobor P., Citrome LL, et al. (2006) Catechol-O- methyltransferase and monoamine oxidase-A polymorphisms and treatment response to typical and atypical neuroleptics. J Clin Psychopharmacol 26 (3). 338-340.
-
(2006)
J Clin Psychopharmacol
, vol.26
, Issue.3
, pp. 338-340
-
-
Nolan, K.A.1
Czobor, P.2
Citrome, L.L.3
-
109
-
-
0029151653
-
Genetic variation of the 5-HT2A receptor and response to clozapine
-
Nothen MM, Rietschel M., Erdmann J., et al. (1995) Genetic variation of the 5-HT2A receptor and response to clozapine. Lancet 346 (8979). 908-909.
-
(1995)
Lancet
, vol.346
, Issue.8979
, pp. 908-909
-
-
Nothen, M.M.1
Rietschel, M.2
Erdmann, J.3
-
110
-
-
0032538921
-
Functional polymorphism of -141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia
-
Ohara K., Nagai M., Tani K., Nakamura Y., Ino A. and Ohara K. (1998) Functional polymorphism of -141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia. Psychiatry Res 81 (2). 117-123.
-
(1998)
Psychiatry Res
, vol.81
, Issue.2
, pp. 117-123
-
-
Ohara, K.1
Nagai, M.2
Tani, K.3
Nakamura, Y.4
Ino, A.5
Ohara, K.6
-
111
-
-
0029869847
-
Drug strategies and treatment-resistant schizophrenia
-
Pantelis C., Barnes TR (1996) Drug strategies and treatment-resistant schizophrenia. Aust N Z J Psychiatry 30 (1). 20-37.
-
(1996)
Aust N Z J Psychiatry
, vol.30
, Issue.1
, pp. 20-37
-
-
Pantelis, C.1
Barnes, T.R.2
-
112
-
-
34948858402
-
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial
-
Patil ST, Zhang L., Martenyi F., et al. (2007) Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat Med 13 (9). 1102-1107.
-
(2007)
Nat Med
, vol.13
, Issue.9
, pp. 1102-1107
-
-
Patil, S.T.1
Zhang, L.2
Martenyi, F.3
-
113
-
-
26444464824
-
Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis
-
Perkins DO, Gu H., Boteva K., Lieberman JA (2005) Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 162 (10). 1785-1804.
-
(2005)
Am J Psychiatry
, vol.162
, Issue.10
, pp. 1785-1804
-
-
Perkins, D.O.1
Gu, H.2
Boteva, K.3
Lieberman, J.A.4
-
114
-
-
0025075626
-
Correlates of rapid neuroleptic response in male patients with schizophrenia
-
Petrie EC, Faustman WO, Moses JA, Lombrozo L., Csernansky JG (1990) Correlates of rapid neuroleptic response in male patients with schizophrenia. Psychiatry Res 33 (2). 171-177.
-
(1990)
Psychiatry Res
, vol.33
, Issue.2
, pp. 171-177
-
-
Petrie, E.C.1
Faustman, W.O.2
Moses, J.A.3
Lombrozo, L.4
Csernansky, J.G.5
-
115
-
-
0022620254
-
Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment
-
Pickar D., Labarca R., Doran AR, et al. (1986) Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment. Arch Gen Psychiatry 43 (7). 669-676.
-
(1986)
Arch Gen Psychiatry
, vol.43
, Issue.7
, pp. 669-676
-
-
Pickar, D.1
Labarca, R.2
Doran, A.R.3
-
116
-
-
0021254347
-
Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients
-
Pickar D., Labarca R., Linnoila M., et al. (1984) Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients. Science 225 (4665). 954-957.
-
(1984)
Science
, vol.225
, Issue.4665
, pp. 954-957
-
-
Pickar, D.1
Labarca, R.2
Linnoila, M.3
-
117
-
-
31544442970
-
First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients
-
Pilowsky LS, Bressan RA, Stone JM, et al. (2006) First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients. Mol Psychiatry 11 (2). 118-119.
-
(2006)
Mol Psychiatry
, vol.11
, Issue.2
, pp. 118-119
-
-
Pilowsky, L.S.1
Bressan, R.A.2
Stone, J.M.3
-
118
-
-
0026643193
-
Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia
-
Pilowsky LS, Costa DC, Ell PJ, Murray RM, Verhoeff NP, Kerwin RW (1992) Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia. Lancet 340 (8813). 199-202.
-
(1992)
Lancet
, vol.340
, Issue.8813
, pp. 199-202
-
-
Pilowsky, L.S.1
Costa, D.C.2
Ell, P.J.3
Murray, R.M.4
Verhoeff, N.P.5
Kerwin, R.W.6
-
119
-
-
0027337646
-
Antipsychotic medication, D2 dopamine receptor blockade and clinical response: A 123I IBZM SPET (single photon emission tomography) study
-
Pilowsky LS, Costa DC, Ell PJ, Murray RM, Verhoeff NP, Kerwin RW (1993) Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123I IBZM SPET (single photon emission tomography) study. Psychol Med 23: 791-797.
-
(1993)
Psychol Med
, vol.23
, pp. 791-797
-
-
Pilowsky, L.S.1
Costa, D.C.2
Ell, P.J.3
Murray, R.M.4
Verhoeff, N.P.5
Kerwin, R.W.6
-
120
-
-
0344951296
-
D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine
-
Potkin SG, Basile VS, Jin Y., et al. (2003) D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine. Mol Psychiatry 8 (1). 109-113.
-
(2003)
Mol Psychiatry
, vol.8
, Issue.1
, pp. 109-113
-
-
Potkin, S.G.1
Basile, V.S.2
Jin, Y.3
-
121
-
-
0019190758
-
Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats
-
Pycock CJ, Kerwin RW, Carter CJ (1980) Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature 286 (5768). 74-76.
-
(1980)
Nature
, vol.286
, Issue.5768
, pp. 74-76
-
-
Pycock, C.J.1
Kerwin, R.W.2
Carter, C.J.3
-
122
-
-
0028172045
-
Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine
-
Rao PA, Pickar D., Gejman PV, Ram A., Gershon ES and Gelernter J. (1994) Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine. Arch Gen Psychiatry 51 (11). 912-917.
-
(1994)
Arch Gen Psychiatry
, vol.51
, Issue.11
, pp. 912-917
-
-
Rao, P.A.1
Pickar, D.2
Gejman, P.V.3
Ram, A.4
Gershon, E.S.5
Gelernter, J.6
-
123
-
-
85047697539
-
Effect of 5-HT1A receptor gene polymorphism on negative and depressive symptom response to antipsychotic treatment of drug-naive psychotic patients
-
Reynolds GP, Arranz B., Templeman LA, Fertuzinhos S., San L. (2006) Effect of 5-HT1A receptor gene polymorphism on negative and depressive symptom response to antipsychotic treatment of drug-naive psychotic patients. Am J Psychiatry 163 (10). 1826-1829.
-
(2006)
Am J Psychiatry
, vol.163
, Issue.10
, pp. 1826-1829
-
-
Reynolds, G.P.1
Arranz, B.2
Templeman, L.A.3
Fertuzinhos, S.4
San, L.5
-
124
-
-
13244262700
-
Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response
-
Reynolds GP, Yao Z., Zhang X., Sun J. and Zhang Z. (2005) Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response. Eur Neuropsychopharmacol 15 (2). 143-151.
-
(2005)
Eur Neuropsychopharmacol
, vol.15
, Issue.2
, pp. 143-151
-
-
Reynolds, G.P.1
Yao, Z.2
Zhang, X.3
Sun, J.4
Zhang, Z.5
-
125
-
-
0030296697
-
Efficacy and side-effects of clozapine: Testing for association with allelic variation in the dopamine D4 receptor gene
-
Rietschel M., Naber D., Oberlander H., et al. (1996) Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene. Neuropsychopharmacology 15 (5). 491-496.
-
(1996)
Neuropsychopharmacology
, vol.15
, Issue.5
, pp. 491-496
-
-
Rietschel, M.1
Naber, D.2
Oberlander, H.3
-
126
-
-
0030738648
-
Efficacy and side-effects of clozapine not associated with variation in the 5-HT2C receptor
-
Rietschel M., Naber D., Fimmers R., Moller HJ, Propping P., Nothen MM (1997) Efficacy and side-effects of clozapine not associated with variation in the 5-HT2C receptor. Neuroreport 8 (8). 1999-2003.
-
(1997)
Neuroreport
, vol.8
, Issue.8
, pp. 1999-2003
-
-
Rietschel, M.1
Naber, D.2
Fimmers, R.3
Moller, H.J.4
Propping, P.5
Nothen, M.M.6
-
127
-
-
0036970070
-
Hippocampal volume in schizophrenia and its relationship with risperidone treatment: A stereological study
-
Savas HA, Unal B., Erbagci H., et al. (2002) Hippocampal volume in schizophrenia and its relationship with risperidone treatment: a stereological study. Neuropsychobiology 46 (2). 61-66.
-
(2002)
Neuropsychobiology
, vol.46
, Issue.2
, pp. 61-66
-
-
Savas, H.A.1
Unal, B.2
Erbagci, H.3
-
128
-
-
0343807441
-
Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene
-
Schafer M., Rujescu D., Giegling I., et al. (2001) Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene. Am J Psychiatry 158 (5). 802-804.
-
(2001)
Am J Psychiatry
, vol.158
, Issue.5
, pp. 802-804
-
-
Schafer, M.1
Rujescu, D.2
Giegling, I.3
-
129
-
-
0032739348
-
Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakastani patients
-
Scharfetter J., Chaudhry HR, Hornik K., et al. (1999) Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakastani patients. Eur Neuropsychopharmacol 10 (1). 17-20.
-
(1999)
Eur Neuropsychopharmacol
, vol.10
, Issue.1
, pp. 17-20
-
-
Scharfetter, J.1
Chaudhry, H.R.2
Hornik, K.3
-
130
-
-
0034845769
-
The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients
-
Scheepers FE, Gispen-de Wied CC, Westenberg HG, Kahn RS (2001) The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients. Neuropsychopharmacology 25 (4). 468-475.
-
(2001)
Neuropsychopharmacology
, vol.25
, Issue.4
, pp. 468-475
-
-
Scheepers, F.E.1
Gispen-De Wied, C.C.2
Westenberg, H.G.3
Kahn, R.S.4
-
131
-
-
0034609249
-
Pharmacogenetics of the clozapine response
-
Schumacher J., Schulze TG, Wienker TF, Rietschel M., Nothen MM (2000) Pharmacogenetics of the clozapine response. Lancet 356 (9228). 506-507.
-
(2000)
Lancet
, vol.356
, Issue.9228
, pp. 506-507
-
-
Schumacher, J.1
Schulze, T.G.2
Wienker, T.F.3
Rietschel, M.4
Nothen, M.M.5
-
132
-
-
47549106824
-
Clozapine interacts with the glycine site of the NMDA receptor: Electrophysiological studies of dopamine neurons in the rat ventral tegmental area
-
Schwieler L., Linderholm KR, Nilsson-Todd LK, Erhardt S., Engberg G. (2008) Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area. Life Sci 83 (5-6). 170-175.
-
(2008)
Life Sci
, vol.83
, Issue.5-6
, pp. 170-175
-
-
Schwieler, L.1
Linderholm, K.R.2
Nilsson-Todd, L.K.3
Erhardt, S.4
Engberg, G.5
-
133
-
-
0010686493
-
Brain receptors for antipsychotic drugs and dopamine: Direct binding assays
-
Seeman P., Chau-Wong M., Tedesco J., Wong K. (1975) Brain receptors for antipsychotic drugs and dopamine: direct binding assays. Proc Natl Acad Sci U S A 72 (11). 4376-4380.
-
(1975)
Proc Natl Acad Sci U S A
, vol.72
, Issue.11
, pp. 4376-4380
-
-
Seeman, P.1
Chau-Wong, M.2
Tedesco, J.3
Wong, K.4
-
134
-
-
0029560535
-
Analysis of clozapine response and polymorphisms of the dopamine D4 receptor gene (DRD4) in schizophrenic patients
-
Shaikh S., Collier DA, Sham P., et al. (1995) Analysis of clozapine response and polymorphisms of the dopamine D4 receptor gene (DRD4) in schizophrenic patients. Am J Med Genet 60 (6). 541-545.
-
(1995)
Am J Med Genet
, vol.60
, Issue.6
, pp. 541-545
-
-
Shaikh, S.1
Collier, D.A.2
Sham, P.3
-
135
-
-
0030005962
-
Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia
-
Shaikh S., Collier DA, Sham PC, et al. (1996) Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia. Hum Genet 97 (6). 714-719.
-
(1996)
Hum Genet
, vol.97
, Issue.6
, pp. 714-719
-
-
Shaikh, S.1
Collier, D.A.2
Sham, P.C.3
-
136
-
-
0023805335
-
The effect of diagnosis and age on the DST: A metaanalytic approach
-
Sharma RP, Pandey GN, Janicak PG, Peterson J., Comaty JE, Davis JM (1988) The effect of diagnosis and age on the DST: a metaanalytic approach. Biol Psychiatry 24 (5). 555-568.
-
(1988)
Biol Psychiatry
, vol.24
, Issue.5
, pp. 555-568
-
-
Sharma, R.P.1
Pandey, G.N.2
Janicak, P.G.3
Peterson, J.4
Comaty, J.E.5
Davis, J.M.6
-
137
-
-
33751331468
-
The relation between peripheral and central glutamate and glutamine in healthy male volunteers
-
Shulman Y., Grant S., Seres P., Hanstock C., Baker G., Tibbo P. (2006) The relation between peripheral and central glutamate and glutamine in healthy male volunteers. J Psychiatry Neurosci 31 (6). 406-410.
-
(2006)
J Psychiatry Neurosci
, vol.31
, Issue.6
, pp. 406-410
-
-
Shulman, Y.1
Grant, S.2
Seres, P.3
Hanstock, C.4
Baker, G.5
Tibbo, P.6
-
138
-
-
0029551796
-
Association between clozapine response and allelic variation in the 5-HT2C receptor gene
-
Sodhi MS, Arranz MJ, Curtis D., et al. (1995) Association between clozapine response and allelic variation in the 5-HT2C receptor gene. Neuroreport 7 (1). 169-172.
-
(1995)
Neuroreport
, vol.7
, Issue.1
, pp. 169-172
-
-
Sodhi, M.S.1
Arranz, M.J.2
Curtis, D.3
-
139
-
-
54849230200
-
Cortical Dopamine D2/D3 Receptors Are a Common Site of Action for Antipsychotic Drugs-An Original Patient Data Meta-analysis of the SPECT and PET in Vivo Receptor Imaging Literature
-
Stone JM, Davis JM, Leucht S., Pilowsky LS (2008 a) Cortical Dopamine D2/D3 Receptors Are a Common Site of Action for Antipsychotic Drugs-An Original Patient Data Meta-analysis of the SPECT and PET In Vivo Receptor Imaging Literature. Schizophr Bull.
-
(2008)
Schizophr Bull
-
-
Stone, J.M.1
Davis, J.M.2
Leucht, S.3
Pilowsky, L.S.4
-
140
-
-
43149093378
-
Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: A [(123)I]CNS-1261 SPET study
-
Berl
-
Stone JM, Erlandsson K., Arstad E., et al. (2008 b) Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: a [(123)I]CNS-1261 SPET study. Psychopharmacology (Berl) 197 (3). 401-408.
-
(2008)
Psychopharmacology
, vol.197
, Issue.3
, pp. 401-408
-
-
Stone, J.M.1
Erlandsson, K.2
Arstad, E.3
-
141
-
-
34447547642
-
Glutamate and dopamine dysregulation in schizophrenia-a synthesis and selective review
-
Stone JM, Morrison PD, Pilowsky LS (2007) Glutamate and dopamine dysregulation in schizophrenia-a synthesis and selective review. J Psychopharmacol 21 (4). 440-452.
-
(2007)
J Psychopharmacol
, vol.21
, Issue.4
, pp. 440-452
-
-
Stone, J.M.1
Morrison, P.D.2
Pilowsky, L.S.3
-
142
-
-
0030903754
-
Prediction of short-term changes in symptom severity by baseline plasma homovanillic acid levels in schizophrenic patients receiving clozapine
-
Sumiyoshi T., Hasegawa M., Jayathilake K., Meltzer HY (1997) Prediction of short-term changes in symptom severity by baseline plasma homovanillic acid levels in schizophrenic patients receiving clozapine. Psychiatry Res 69 (2-3). 113-121.
-
(1997)
Psychiatry Res
, vol.69
, Issue.2-3
, pp. 113-121
-
-
Sumiyoshi, T.1
Hasegawa, M.2
Jayathilake, K.3
Meltzer, H.Y.4
-
143
-
-
0034889660
-
2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients
-
DOI 10.1097/00008571-200108000-00009
-
Suzuki A., Kondo T., Mihara K., et al. (2001) The -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients. Pharmacogenetics 11 (6). 545-550. (Pubitemid 32778231)
-
(2001)
Pharmacogenetics
, vol.11
, Issue.6
, pp. 545-550
-
-
Suzuki, A.1
Kondo, T.2
Mihara, K.3
Yasui-Furukori, N.4
Ishida, M.5
Furukori, H.6
Kaneko, S.7
Inoue, Y.8
Otani, K.9
-
144
-
-
0033623809
-
2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients
-
Suzuki A., Mihara K., Kondo T., et al. (2000) The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients. Pharmacogenetics 10 (4). 335-341. (Pubitemid 30345181)
-
(2000)
Pharmacogenetics
, vol.10
, Issue.4
, pp. 335-341
-
-
Suzuki, A.1
Mihara, K.2
Kondo, T.3
Tanaka, O.4
Nagashima, U.5
Otani, K.6
Kaneko, S.7
-
145
-
-
0347363538
-
Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia
-
Szekeres G., Keri S., Juhasz A., et al. (2004) Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 124B (1). 1-5.
-
(2004)
Am J Med Genet B Neuropsychiatr Genet
, vol.124
, Issue.1
, pp. 1-5
-
-
Szekeres, G.1
Keri, S.2
Juhasz, A.3
-
146
-
-
26244458916
-
The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS)
-
Szulc A., Galinska B., Tarasow E., et al. (2005) The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS). Pharmacopsychiatry 38 (5). 214-219.
-
(2005)
Pharmacopsychiatry
, vol.38
, Issue.5
, pp. 214-219
-
-
Szulc, A.1
Galinska, B.2
Tarasow, E.3
-
147
-
-
0028887499
-
Clozapine effects on neuroendocrine response to apomorphine challenge testing in chronic neuroleptic nonresponsive schizophrenia: Preliminary findings
-
Szymanski S., Lieberman J., Pollack S., et al. (1995) Clozapine effects on neuroendocrine response to apomorphine challenge testing in chronic neuroleptic nonresponsive schizophrenia: preliminary findings. Biol Psychiatry 37 (1). 52-55.
-
(1995)
Biol Psychiatry
, vol.37
, Issue.1
, pp. 52-55
-
-
Szymanski, S.1
Lieberman, J.2
Pollack, S.3
-
148
-
-
0031776804
-
The role of negative symptoms and cognitive dysfunction in schizophrenia outcome
-
Tamminga CA, Buchanan RW, Gold JM (1998) The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. Int Clin Psychopharmacol 13 (Suppl 3). S21 - S26.
-
(1998)
Int Clin Psychopharmacol
, vol.13
, Issue.3
-
-
Tamminga, C.A.1
Buchanan, R.W.2
Gold, J.M.3
-
149
-
-
0025829372
-
Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement, and outcome
-
Tandon R., Mazzara C., DeQuardo J., et al. (1991) Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome. Biol Psychiatry 29 (10). 953-964.
-
(1991)
Biol Psychiatry
, vol.29
, Issue.10
, pp. 953-964
-
-
Tandon, R.1
Mazzara, C.2
Dequardo, J.3
-
150
-
-
0034283750
-
Association study of a functional serotonin transporter gene polymorphism with schizophrenia, psychopathology and clozapine response
-
Tsai SJ, Hong CJ, Yu YW, et al. (2000) Association study of a functional serotonin transporter gene polymorphism with schizophrenia, psychopathology and clozapine response. Schizophr Res 44 (3). 177-181.
-
(2000)
Schizophr Res
, vol.44
, Issue.3
, pp. 177-181
-
-
Tsai, S.J.1
Hong, C.J.2
Yu, Y.W.3
-
151
-
-
0035871218
-
Association analysis of polymorphism in the promoter region of the alpha2a-adrenoceptor gene with schizophrenia and clozapine response
-
Tsai SJ, Wang YC, Yu Younger WY, Lin CH, Yang KH, Hong CJ (2001) Association analysis of polymorphism in the promoter region of the alpha2a-adrenoceptor gene with schizophrenia and clozapine response. Schizophr Res 49 (1-2). 53-58.
-
(2001)
Schizophr Res
, vol.49
, Issue.1-2
, pp. 53-58
-
-
Tsai, S.J.1
Wang, Y.C.2
Yu Younger, W.Y.3
Lin, C.H.4
Yang, K.H.5
Hong, C.J.6
-
152
-
-
33745703902
-
Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond
-
Tunbridge EM, Harrison PJ, Weinberger DR (2006) Catechol-o- methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry 60 (2). 141-151.
-
(2006)
Biol Psychiatry
, vol.60
, Issue.2
, pp. 141-151
-
-
Tunbridge, E.M.1
Harrison, P.J.2
Weinberger, D.R.3
-
153
-
-
9244243064
-
Glutamatergic drugs for schizophrenia: A systematic review and meta-analysis
-
Tuominen HJ, Tiihonen J., Wahlbeck K. (2005) Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis. Schizophr Res 72 (2-3). 225-234.
-
(2005)
Schizophr Res
, vol.72
, Issue.2-3
, pp. 225-234
-
-
Tuominen, H.J.1
Tiihonen, J.2
Wahlbeck, K.3
-
154
-
-
1642603457
-
Atypical antipsychotics and the relevance of glutamate and serotonin
-
van der Heijden FM, Tuinier S., Fekkes D., Sijben AE, Kahn RS, Verhoeven WM (2004) Atypical antipsychotics and the relevance of glutamate and serotonin. Eur Neuropsychopharmacol 14 (3). 259-265.
-
(2004)
Eur Neuropsychopharmacol
, vol.14
, Issue.3
, pp. 259-265
-
-
Van Der Heijden, F.M.1
Tuinier, S.2
Fekkes, D.3
Sijben, A.E.4
Kahn, R.S.5
Verhoeven, W.M.6
-
155
-
-
0030606867
-
Predicting haloperidol treatment response in chronic schizophrenia
-
van Kammen DP, Kelley ME, Yao JK, et al. (1996) Predicting haloperidol treatment response in chronic schizophrenia. Psychiatry Res 64 (1). 47-58.
-
(1996)
Psychiatry Res
, vol.64
, Issue.1
, pp. 47-58
-
-
Van Kammen, D.P.1
Kelley, M.E.2
Yao, J.K.3
-
156
-
-
7444232703
-
Catechol-Omethyltransferase val108/158met genotype predicts working memory response to antipsychotic medications
-
Weickert TW, Goldberg TE, Mishara A., et al. (2004) Catechol- Omethyltransferase val108/158met genotype predicts working memory response to antipsychotic medications. Biol Psychiatry 56 (9). 677-682.
-
(2004)
Biol Psychiatry
, vol.56
, Issue.9
, pp. 677-682
-
-
Weickert, T.W.1
Goldberg, T.E.2
Mishara, A.3
-
157
-
-
0018842984
-
Cerebral ventricular enlargement in chronic schizophrenia. An association with poor response to treatment
-
Weinberger DR, Bigelow LB, Kleinman JE, Klein ST, Rosenblatt JE, Wyatt RJ (1980) Cerebral ventricular enlargement in chronic schizophrenia. An association with poor response to treatment. Arch Gen Psychiatry 37 (1). 11-13.
-
(1980)
Arch Gen Psychiatry
, vol.37
, Issue.1
, pp. 11-13
-
-
Weinberger, D.R.1
Bigelow, L.B.2
Kleinman, J.E.3
Klein, S.T.4
Rosenblatt, J.E.5
Wyatt, R.J.6
-
158
-
-
33846624143
-
COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia
-
Woodward ND, Jayathilake K. and Meltzer HY (2007) COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia. Schizophr Res 90 (1-3). 86-96.
-
(2007)
Schizophr Res
, vol.90
, Issue.1-3
, pp. 86-96
-
-
Woodward, N.D.1
Jayathilake, K.2
Meltzer, H.Y.3
-
159
-
-
13444301359
-
Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients
-
Wu S., Xing Q., Gao R., et al. (2005) Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients. Neurosci Lett 376 (1). 1-4.
-
(2005)
Neurosci Lett
, vol.376
, Issue.1
, pp. 1-4
-
-
Wu, S.1
Xing, Q.2
Gao, R.3
-
160
-
-
33746466663
-
Association of DRD2 polymorphisms and chlorpromazine-induced extrapyramidal syndrome in Chinese schizophrenic patients
-
Wu SN, Gao R., Xing QH, et al. (2006) Association of DRD2 polymorphisms and chlorpromazine-induced extrapyramidal syndrome in Chinese schizophrenic patients. Acta Pharmacol Sin 27 (8). 966-970.
-
(2006)
Acta Pharmacol Sin
, vol.27
, Issue.8
, pp. 966-970
-
-
Wu, S.N.1
Gao, R.2
Xing, Q.H.3
-
161
-
-
34948887131
-
The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients
-
Xing Q., Qian X., Li H., et al. (2007) The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients. Int J Neuropsychopharmacol 10 (5). 631-637.
-
(2007)
Int J Neuropsychopharmacol
, vol.10
, Issue.5
, pp. 631-637
-
-
Xing, Q.1
Qian, X.2
Li, H.3
-
162
-
-
0036197150
-
Different neuroendocrine profiles of remitted and nonremitted schizophrenic patients
-
Yazici K., Yazici AE, Taneli B. (2002) Different neuroendocrine profiles of remitted and nonremitted schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 26 (3). 579-584.
-
(2002)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.26
, Issue.3
, pp. 579-584
-
-
Yazici, K.1
Yazici, A.E.2
Taneli, B.3
-
163
-
-
0025279268
-
The incidence of abnormal dexamethasone suppression in schizophrenia: A review and a meta-analytic comparison with the incidence in normal controls
-
Yeragani VK (1990) The incidence of abnormal dexamethasone suppression in schizophrenia: a review and a meta-analytic comparison with the incidence in normal controls. Can J Psychiatry 35 (2). 128-132.
-
(1990)
Can J Psychiatry
, vol.35
, Issue.2
, pp. 128-132
-
-
Yeragani, V.K.1
-
164
-
-
0037347232
-
Plasma levels of homovanillic acid and the response to risperidone in first episode untreated acute schizophrenia
-
Yoshimura R., Ueda N., Shinkai K., Nakamura J. (2003) Plasma levels of homovanillic acid and the response to risperidone in first episode untreated acute schizophrenia. Int Clin Psychopharmacol 18 (2). 107-111.
-
(2003)
Int Clin Psychopharmacol
, vol.18
, Issue.2
, pp. 107-111
-
-
Yoshimura, R.1
Ueda, N.2
Shinkai, K.3
Nakamura, J.4
-
165
-
-
0033606080
-
Serotonin-6 receptor variant (C267T) and clinical response to clozapine
-
Yu YW, Tsai SJ, Lin CH, Hsu CP, Yang KH, Hong CJ (1999) Serotonin-6
-
(1999)
Neuroreport
, vol.10
, Issue.6
, pp. 1231-1233
-
-
Yu, Y.W.1
Tsai, S.J.2
Lin, C.H.3
Hsu, C.P.4
Yang, K.H.5
Hong, C.J.6
-
166
-
-
34948897970
-
Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients
-
Zai CC, Hwang RW, De Luca V., et al. (2007) Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients. Int J Neuropsychopharmacol 10 (5). 639-651.
-
(2007)
Int J Neuropsychopharmacol
, vol.10
, Issue.5
, pp. 639-651
-
-
Zai, C.C.1
Hwang, R.W.2
De Luca, V.3
-
167
-
-
12444307546
-
DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: A pilot pharmacogenetic study
-
Zalsman G., Frisch A., Lev-Ran S., et al. (2003) DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic study. Eur Neuropsychopharmacol 13 (3). 183-185.
-
(2003)
Eur Neuropsychopharmacol
, vol.13
, Issue.3
, pp. 183-185
-
-
Zalsman, G.1
Frisch, A.2
Lev-Ran, S.3
-
168
-
-
27744556147
-
Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine
-
Zhao AL, Zhao JP, Zhang YH, Xue ZM, Chen JD and Chen XG (2005) Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine. Int J Neurosci 115 (11). 1539-1547.
-
(2005)
Int J Neurosci
, vol.115
, Issue.11
, pp. 1539-1547
-
-
Zhao, A.L.1
Zhao, J.P.2
Zhang, Y.H.3
Xue, Z.M.4
Chen, J.D.5
Chen, X.G.6
-
169
-
-
0032570843
-
MRI correlates of treatment response in first episode psychosis
-
Zipursky RB, Zhang-Wong J., Lambe EK, Bean G., Beiser M. (1998) MRI correlates of treatment response in first episode psychosis. Schizophr Res 30 (1). 81-90.
-
(1998)
Schizophr Res
, vol.30
, Issue.1
, pp. 81-90
-
-
Zipursky, R.B.1
Zhang-Wong, J.2
Lambe, E.K.3
Bean, G.4
Beiser, M.5
|